María Tejera Ruiz
mariatejeraruiz.bsky.social
María Tejera Ruiz
@mariatejeraruiz.bsky.social
PhD Student at University of Zaragoza
Química oro y plata-PDT section💫
Bioinorganic chemistry🧫
Reposted by María Tejera Ruiz
Now #OpenAccess in Journal of Medicinal Chemistry!
We present ViVo: A Temporal Modeling Framework That Boosts Statistical Power and Minimizes Animal Usage | pubs.acs.org/doi/10.1021/...
Congratulations and thanks to @conchitagimeno.bsky.social, R. P. Herrera and E. Romanos 🐁📊💊
#3Rs #oncology
ViVo: A Temporal Modeling Framework That Boosts Statistical Power and Minimizes Animal Usage
Preclinical tumor studies are often limited by high variability and small-sample sizes, reducing statistical power, and masking treatment effects. We present an exponential framework that estimates tu...
pubs.acs.org
January 3, 2026 at 5:45 PM
Reposted by María Tejera Ruiz
Tremendously happy to finally see this work published! A wonderful collaboration with colleagues from the University of Vigo. Very proud of the team and the journey behind this study. pubs.rsc.org/en/content/a...
Structure–activity insights into benzimidazole-based Ir(III) cyclometallated complexes for cancer therapy
A family of cyclometallated Ir(iii) complexes incorporating benzimidazole-based C^N ligands and ancillary diimines with distinct functionalities, 2-(pyridin-2-yl)-1H-benzo[d]imidazole (L1), 4-(1H-benz...
pubs.rsc.org
December 15, 2025 at 10:05 PM
Reposted by María Tejera Ruiz
👉𝐂𝐨𝐧𝐣𝐮𝐠𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐚 𝐜𝐲𝐜𝐥𝐨𝐦𝐞𝐭𝐚𝐥𝐚𝐭𝐞𝐝 𝐈𝐫(𝐢𝐢𝐢) 𝐜𝐨𝐦𝐩𝐥𝐞𝐱 𝐭𝐨 𝐡𝐮𝐦𝐚𝐧 𝐬𝐞𝐫𝐮𝐦 𝐚𝐥𝐛𝐮𝐦𝐢𝐧 𝐟𝐨𝐫 𝐨𝐧𝐜𝐨𝐬𝐢𝐬-𝐦𝐞𝐝𝐢𝐚𝐭𝐞𝐝 𝐩𝐡𝐨𝐭𝐨𝐝𝐲𝐧𝐚𝐦𝐢𝐜 𝐭𝐡𝐞𝐫𝐚𝐩𝐲 by Johannes Karges 𝘦𝘵 𝘢𝘭.

The conjugation of a cyclometalated Ir(III) complex to human serum albumin for oncosis mediated photodynamic therapy is reported.
🔗 doi.org/10.1039/D5QI01287B
Conjugation of a cyclometalated Ir(III) complex to human serum albumin for oncosis-mediated photodynamic therapy
Anticancer agents often rely on apoptosis, limiting their effectiveness and leading to drug resistance. To address these issues, alternative cell death mechanisms have gained attention. To date, only ...
pubs.rsc.org
November 4, 2025 at 7:09 AM
Reposted by María Tejera Ruiz
Happy #pride month! We believe that chemistry is for everyone. In the face of opposition that threatens the progress we've made, it's never been more important for us to promote equality of opportunities and make chemistry as open, inclusive and diverse as it should be: buff.ly/1dShs0l #ChemSky
June 4, 2025 at 12:01 PM